Long-term persistent donor-recipient mixed chimerism without disease recurrence after myeloablative single-unit cord blood transplantation in adult acute myeloid leukemia following myelodysplastic syndrome

Leuk Lymphoma. 2017 Dec;58(12):2973-2975. doi: 10.1080/10428194.2017.1318440. Epub 2017 May 16.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers
  • Bone Marrow / metabolism
  • Bone Marrow / pathology
  • Cord Blood Stem Cell Transplantation* / adverse effects
  • Cord Blood Stem Cell Transplantation* / methods
  • Disease Progression
  • Graft vs Host Disease / diagnosis
  • Graft vs Host Disease / etiology
  • Humans
  • In Situ Hybridization, Fluorescence
  • Leukemia, Myeloid, Acute / diagnosis
  • Leukemia, Myeloid, Acute / pathology*
  • Leukemia, Myeloid, Acute / therapy*
  • Male
  • Myelodysplastic Syndromes / diagnosis
  • Myelodysplastic Syndromes / pathology*
  • Recurrence
  • Transplantation Chimera*
  • Treatment Outcome

Substances

  • Biomarkers